The clinical course of acetaminophen toxicity generally is divided into four phases. Physical findings may vary, depending on the degree of hepatotoxicity. 
Management
Gastrointestinal decontamination agents can be used in the emergency setting during the immediate postingestion time frame. Administer activated charcoal (AC) if the patient is alert and presents, ideally, within 1 hour post ingestion. This time frame can be extended if the patient has ingested an acetaminophenbased sustainedrelease medication or if the ingestion includes agents that are known to slow gastric emptying. Patients with acetaminophen concentrations below the "possible" line for hepatotoxicity on the RumackMatthew nomogram may be discharged home after they are medically cleared.
Admit patients with acetaminophen concentration above the "possible" line on the RumackMatthew nomogram for treatment with N acetylcysteine (NAC). NAC is nearly 100% hepatoprotective when it is given within 8 hours after an acute acetaminophen ingestion, but can be beneficial in patients who present more than 24 hours after ingestion. NAC is approved for both oral and IV administration.
The FDAapproved regimen for oral administration of NAC (Mucomyst) is as follows:
Loading dose of 140 mg/kg 17 doses of 70 mg/kg given every 4 hours Total treatment duration of 72 hours
The IV formulation of NAC (Acetadote) is commonly used in many institutions for the treatment of acetaminophen ingestion. Use of the IV formulation of NAC is preferred in the following situations: 
